Ledger.Open graph →
SEC Form D · filed July 2, 2024

Eliem Therapeutics, Inc

Offering
$120.0M
Sold
$120.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WILMINGTON, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Judith Dunn · Wilmington, DEDirectorAdam Rosenberg · Wilmington, DEDirectorAndrew Levin · Wilmington, DEExec · DirectorStephen Thomas · Wilmington, DEDirectorValerie Morisset · Wilmington, DEExecAoife Brennan · Wilmington, DEExec · DirectorLiam Ratcliffe · Wilmington, DEDirectorSimon Tate · Wilmington, DEDirectorAndrew Levin · Wilmington, DEExec · DirectorJudith Dunn · Wilmington, DEDirectorAdam Rosenberg · Wilmington, DEDirectorValerie Morisset · Wilmington, DEExecAoife Brennan · Wilmington, DEExec · DirectorLiam Ratcliffe · Wilmington, DEDirectorSimon Tate · Wilmington, DEDirectorStephen Thomas · Wilmington, DEDirectorOSL Storage VI Investment Co, LLC · Dallas, TXDirectorNull Baceline Investments, LLC · Denver, CODirectorKarl Gorin · St. Helier, Y9DirectorDanielle Bisson · St. Helier, Y9DirectorRyan Markowski · Wilton Manors, FLExec · DirectorTianyu G. Zhou · La Jolla, CAExec · DirectorMark G. Bertagnolli · La Jolla, CADirectorDouglas G. Wall · La Jolla, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗